EP1616882 - Apo-2 receptor antibodies [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 24.08.2012 Database last updated on 19.10.2024 | Most recent event Tooltip | 24.08.2012 | Application deemed to be withdrawn | published on 26.09.2012 [2012/39] | Applicant(s) | For all designated states Genentech, Inc. 1 DNA Way South San Francisco, CA 94080-4990 / US | [N/P] |
Former [2006/03] | For all designated states GENENTECH, INC. 1 DNA Way South San Francisco, CA 94080-4990 / US | Inventor(s) | 01 /
Ashkenazi, Avi, J 1456 Tarrytown Street San Mateo, CA 94402 / US | 02 /
Chuntherapai, Anan 826 Ellis Drive Colma, CA 94015 / US | 03 /
Kim, K, Jin 622 Benvenue Avenue Los Altos, CA 94024 / US | [2006/03] | Representative(s) | Kiddle, Simon John, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | [N/P] |
Former [2006/03] | Kiddle, Simon John, et al Mewburn Ellis LLP York House, 23 Kingsway London WC2B 6HP / GB | Application number, filing date | 05014041.7 | 14.09.2000 | [2006/03] | Priority number, date | US19990396710 | 15.09.1999 Original published format: US 396710 | [2006/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP1616882 | Date: | 18.01.2006 | Language: | EN | [2006/03] | Type: | A3 Search report | No.: | EP1616882 | Date: | 28.02.2007 | [2007/09] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 26.01.2007 | Classification | IPC: | A61K39/395, A61P35/00 | [2007/09] | CPC: |
C07K14/70578 (EP);
A61P35/00 (EP);
C07K16/2878 (EP);
A61K2039/505 (EP);
C07K2317/73 (EP);
C07K2317/75 (EP);
|
Former IPC [2006/03] | C07K16/28, A61K39/395, A61P35/00 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2006/03] | Title | German: | Apo-2 Rezeptor Antikörper | [2006/03] | English: | Apo-2 receptor antibodies | [2006/03] | French: | Anticorps dirigés contre le récepteur APO-2 | [2006/03] | Biological material | This application mentions deposited biological material, check the file for details | Examination procedure | 18.07.2005 | Examination requested [2006/03] | 30.03.2009 | Despatch of a communication from the examining division (Time limit: M06) | 20.01.2010 | Reply to a communication from the examining division | 01.04.2012 | Application deemed to be withdrawn, date of legal effect [2012/39] | 09.05.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2012/39] | Parent application(s) Tooltip | EP00963542.6 / EP1226161 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20000963542) is 07.06.2004 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 20.01.2010 | Request for further processing filed | 20.01.2010 | Full payment received (date of receipt of payment) | Fees paid | Renewal fee | 18.07.2005 | Renewal fee patent year 03 | 18.07.2005 | Renewal fee patent year 04 | 18.07.2005 | Renewal fee patent year 05 | 18.07.2005 | Renewal fee patent year 06 | 11.09.2006 | Renewal fee patent year 07 | 12.09.2007 | Renewal fee patent year 08 | 15.09.2008 | Renewal fee patent year 09 | 11.09.2009 | Renewal fee patent year 10 | 14.09.2010 | Renewal fee patent year 11 | Penalty fee | Additional fee for renewal fee | 30.09.2011 | 12   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO9851793 (GENENTECH INC [US]) [X] 1,2,6,10-13 * page 1, lines 1-6 * * page 7, line 22 - page 9, line 28 * * page 19, lines 8-34 * * page 47, line 3 - page 62, line 10; examples 10,14-16 *; | [A]WO9858062 (GENENTECH INC [US]) [A] 1-5 * abstract * * page 3, line 5 - page 6, line 12 * * page 29, line 30 - page 36, line 6; example 13 *; | [PX]US6046048 (ASHKENAZI AVI J [US], et al) [PX] 1-5,10-13* column 3, line 54 - column 4, line 15; examples 5,9-12,14 *; | [X] - CHUNTHARAPAI A ET AL, "The induction and blocking of apoptosis by anti Apo2 monoclonal antibodies.", FASEB JOURNAL, Annual Meeting of the Professional Research Scientists for Experimental Biology 99;Washington, D.C., USA; April 17-21, 1999, (19990312), vol. 13, no. 4 PART 1, ISSN 0892-6638, page A518, XP000982649 [X] 1-5 * abstract * | [DA] - ASHKENAZI A ET AL, "INDUCTION OF APOPTOSIS BY APO-2 LIGAND, A NEW MEMBER OF THE TUMOR NECROSIS FACTOR CYTOKINE FAMILY", EUROPEAN CYTOKINE NETWORK, (19960401), XP000672223 [DA] 1 * the whole document * | [DA] - PITTI R M ET AL, "INDUCTION OF APOPTOSIS BY APO-2 LIGAND, A NEW MEMBER OF THE TUMOR NECROSIS FACTOR CYTOKINE FAMILY", JOURNAL OF BIOLOGICAL CHEMISTRY,US,AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, (19960531), vol. 271, no. 22, ISSN 0021-9258, pages 12687 - 12690, XP002031265 [DA] 1 * the whole document * DOI: http://dx.doi.org/10.1074/jbc.271.22.12687 |